US FDA to Hold Advisory Meeting to Review Grail's Multi-cancer Test

https://www.medscape.com/s/viewarticle/us-fda-hold-advisory-meeting-review-grails-multi-cancer-test-2026a1000r35?ecd=wnl_edit_tpal_etid8580518&uac=148436CN&impID=8580518 Aug 7 (Reuters) - Grail said on Friday the U.S. FDA plans to hold a meeting of outside experts to review its multi-cancer screening test ⁠Galleri in September, sending its shares up 5%.